UBS O'Connor’s Oric Pharmaceuticals ORIC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $497K | Buy |
49,000
+1,358
| +3% | +$13.8K | 0.03% | 248 |
|
|
2025
Q1 | $266K | Sell |
47,642
-127,204
| -73% | -$710K | 0.01% | 214 |
|
|
2024
Q4 | $1.41M | Buy |
174,846
+31,526
| +22% | +$254K | 0.04% | 196 |
|
|
2024
Q3 | $1.47M | Buy |
143,320
+28,954
| +25% | +$297K | 0.04% | 221 |
|
|
2024
Q2 | $809K | Buy |
114,366
+22,000
| +24% | +$156K | 0.02% | 320 |
|
|
2024
Q1 | $1.27M | Sell |
92,366
-170,590
| -65% | -$2.35M | 0.04% | 245 |
|
|
2023
Q4 | $2.42M | Sell |
262,956
-88,546
| -25% | -$815K | 0.08% | 149 |
|
|
2023
Q3 | $2.13M | Sell |
351,502
-10,000
| -3% | -$60.5K | 0.04% | 236 |
|
|
2023
Q2 | $2.81M | Sell |
361,502
-1,205
| -0.3% | -$9.35K | 0.06% | 206 |
|
|
2023
Q1 | $2.07M | Buy |
+362,707
| New | +$2.07M | 0.05% | 305 |
|
|
2022
Q4 | – | Sell |
-343,002
| Closed | -$1.1M | – | 225 |
|
|
2022
Q3 | $1.1M | Sell |
343,002
-18,053
| -5% | -$57.8K | 0.01% | 724 |
|
|
2022
Q2 | $1.62M | Buy |
+361,055
| New | +$1.62M | 0.02% | 687 |
|